LPBI’s Perspective on Medical and Life Sciences Applications – 3D Printing: BioInks, BioMaterials-BioPolymer
Curator: Aviva Lev-Ari, PhD, RN
1 | 2 | 3 |
4 |
|
Tissue Engineering & BioPrinting in Regenerative Medicine | Pharmaceutical Applications: Drug Printing and Drug Dosing | Bone-related Applications:
Orthopedic and Dental |
Cardiovascular Tissue, Artificial Vascular Structures (artery-on-a-chip) | |
Current Relations | RegenHU’s BioInk
& |
SBH Sciences, Inc
& |
Vivos-Dental
& |
Valvecure.com
Telerescue.com |
Team Members Expertise | Dr. Irina Robu
Gerard Loiseau |
Dr. Raphael Nir
Dr. Peter Nelboeck Dr. Williams |
Dr. Irina Robu | Dr. Justin Pearlman, MD, PhD, FACC
Aviva Lev-Ari, PhD, RN Yoel Ezra |
Industry Leaders | Organovo Holdings, Inc. (ONVO.PK)
& 22 Israeli start ups http://www.iati.co.il/sub-category/18/2/tissue-engineering-cell-therapy- |
· ROCHE
· Novastis · J&J · Merck · Roche’s R&D spending in 2013: $10 billion. As a percentage of revenue: 19% Leading the healthcare industry in R&D spending, the Swiss biopharmaceutical company spends more today than it did when it topped the Strategy& list three years ago. The company invests an overwhelming majority of its R&D budget —almost 90%—on pharmaceuticals, while the rest goes into diagnostics. Oncology, the largest part of Roche’s business, eats about half of its pharma R&D spending. One of the company’s latest drugs, a targeted medicine for advanced breast cancer called Kadcyla, was approved in the U.S. and E.U. last year. Roche says it is looking to leverage parts of the Kadcyla platform (for instance, the innovative way it links chemotherapeutic agents and antibodies) for future drugs. · |
Zimmer
Stryker Cooper Wright Medical ResMed Inc Steris Corp Sirona Dental Systems Varian Medical Systems CareFusion Natus Medical Smith & Nephew |
Medtronic
Abbott Labs Baxter Johnson&Johnson Engologix Boston Scientific St Jude Medical Becton Dickson EdwardsLS Bard (C.R.) |
Sources | Workshop-Handout-Tissue-Engineered-Medical-Products – Lack E. Lemons, PhD | http://pharmaceuticalintelligence.com/medical-3d-printing/ | Oxford Performance Materials gets FDA nod for 3-D printed spinal implant | http://pharmaceuticalintelligence.com/medical-3d-printing/ |
Leave a Reply